BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2080240)

  • 1. The occurrence of carbohydrate antigens (CA 19-9, CA-50) in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Acta Histochem Suppl; 1990; 38():183-7. PubMed ID: 2080240
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Makovitzky J; Schwenk J
    Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
    [No Abstract]   [Full Text] [Related]  

  • 3. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lex and Ley antigen expression in human pancreatic cancer.
    Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
    Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Pancreatic polypeptide" A cells. Demonstration in the adult human pancreas and role in pancreatic pathology].
    Berger G; Guillaud MM; Patricot LM; Beau G; Toccanier MF
    Arch Anat Cytol Pathol; 1978; 26(3-4):153-7. PubMed ID: 373648
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F; Roscher R; Beger HG
    Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic carcinoma developing in chronic pancreatitis: a report of four cases.
    Haas O; Guillard G; Rat P; Friedman S; Favre JP
    Hepatogastroenterology; 1990 Jun; 37(3):350-1. PubMed ID: 2373470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas].
    Schlosser W; Schoenberg MH; Rhein E; Siech M; Gansauge F; Beger HG
    Z Gastroenterol; 1996 Jan; 34(1):3-8. PubMed ID: 8776168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F; Roscher R; Beger HG
    Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood CA 19-9 in the diagnosis of carcinoma of the pancreas: a critical approach].
    Angonese C; Basso D; Del Favero G; Fabris C; Tremolada C; Plebani M; Burlina A; Naccarato R
    Ann Ital Med Int; 1987; 2(2):138-42. PubMed ID: 3275279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunology of acute and chronic pancreatitis].
    Pour PM; Takasaki H; Büchler M
    Verh Dtsch Ges Pathol; 1987; 71():255-65. PubMed ID: 3481506
    [No Abstract]   [Full Text] [Related]  

  • 18. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.